Literature DB >> 11354797

[Source of plasminogen activator in rhesus monkey semen and its possible role in sperm capacitation].

P Zheng1, R J Zou, Y X Liu.   

Abstract

Previous studies have demonstrated that plasminogen activator (PA) activity is significantly high in semen of infertile men, which is also high in semen when azoospermia or oligozoospermia is induced by injection of testosterone enanthate (TE) into healthy adult men or rhesus monkeys. To further clarify the source and possible role of PA in semen, the present study was undertaken to examine: (1) whether the mRNAs for tissue type PA (tPA), urokinase type PA (uPA), and PA inhibitor-1 (PAI-1) are expressed in epididymis, seminal vesicle and prostate gland of rhesus monkeys; and (2) whether PA has some effect on in vitro sperm capacitation as judged by the potential of sperm motility, acrosome reaction (AR) and in vitro fertilization. Our results showed that (1) mRNAs for PA and PAI-1 were expressed in epididymis, seminal vesicle and prostate gland, and (2) uPA, but not tPA, improved sperm mobility, induced AR and enhanced sperm capacity to fertilize mature eggs. Thus, it is concluded that PA activity in semen comes not only from testis and epididymis, but also from seminal vesicle and prostate gland; and that uPA, but not tPA, may play a role in sperm capacitation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11354797

Source DB:  PubMed          Journal:  Sheng Li Xue Bao        ISSN: 0371-0874


  2 in total

1.  Urokinase-type plasminogen activator: a new target for male contraception?

Authors:  Ying Qin; Yan Han; Cheng-Liang Xiong; Hong-Gang Li; Lian Hu; Ling Zhang
Journal:  Asian J Androl       Date:  2015 Mar-Apr       Impact factor: 3.285

Review 2.  Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.

Authors:  Niaz Mahmood; Catalin Mihalcioiu; Shafaat A Rabbani
Journal:  Front Oncol       Date:  2018-02-12       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.